CNA Financial (CNA) Q4 2025 earnings review
Record Year, but Fourth Quarter Shows Brakes Screeching
CNA delivered a record full-year performance, but Q4 revealed emerging friction. While Net Income surged to $302M (lapping a massive pension charge in the prior year), the core operating metrics painted a tougher picture: Core Income fell 7%, the Underlying Combined Ratio deteriorated by 90 basis points, and Net Written Premium growth slowed to a crawl at 2%. Management is leaning heavily on 'underwriting discipline'—walking away from bad risk—but the result is a distinct deceleration in top-line growth combined with margin compression in the Specialty segment.
🐂 Bull Case
The portfolio remains a fortress. Net Investment Income hit $653M (+1% YoY), with Fixed Income up 5%. Reinvestment rates continue to exceed portfolio yields, providing a growing, predictable earnings floor.
Confidence in capital position is high. CNA raised the quarterly dividend by 4% to $0.48 and declared a substantial $2.00 special dividend, offering an attractive ~8% yield at current prices.
🐻 Bear Case
The Specialty segment is flashing red. The underlying combined ratio jumped to 96.0% (vs 93.8% last year), driven by a 1.7pt expense spike and loss ratio pressure. With pricing flat-to-negative in management liability, margins are being squeezed.
Underwriting discipline is prudent, but growth has effectively vanished. Net Written Premium growth decelerated from 9% in Q1 to just 2% in Q4. New business was flat.
⚖️ Verdict: ⚪
Neutral. The dividend yield and investment income provide a high floor, but the core underwriting engine is sputtering. Deteriorating margins in Specialty and stalling growth suggest the 'easy' post-pandemic wins are over.
Key Themes
Specialty Segment Margin Compression
Specialty, historically a profit driver, stumbled significantly. The underlying combined ratio deteriorated to 96.0% from 93.8% a year ago. While management blamed a 'non-recurring technology charge' for the expense ratio spike, the underlying loss ratio also ticked up 0.5 points. Coupled with a 2% decline in Net Written Premiums, this segment is shrinking and becoming less profitable simultaneously.
Investment Income Reliability
Fixed income remains the bedrock of CNA's earnings. Income from fixed maturities rose to $576M (+5% YoY) due to a larger asset base and favorable reinvestment rates (new money rates match Life & Group yield of 5.7% and beat P&C yield of 4.4%). Guidance for 2026 suggests continued stability, projecting ~$2.325B in fixed income earnings.
Legacy Liability Drag
The Corporate segment recorded a core loss of $103M, worsening from -$91M last year. The culprit: a $67M after-tax charge related to Asbestos & Environmental Pollution (A&EP) reserves following the annual Q4 review. This recurring 'legacy' drag continues to obscure the profitability of the active business.
Commercial Segment Resilience
Amidst the slowdown, Commercial remains a bright spot. It delivered an underwriting gain of $109M (record high) and kept the underlying combined ratio nearly flat at 90.2%. Rates held up well (+3% aggregate, excluding work comp is +5%), and Double-digit rate increases in commercial auto and excess casualty persist.
Life & Group Swing to Loss
The Life & Group segment swung to a core loss of $29M (vs $18M loss in PY), driven by unfavorable persistency. While not the core business, this volatility drags on consolidated ROE.
Other KPIs
Decelerating. Down 7% vs $342M in 24Q4. While Full Year 2025 was a record ($1.34B), the Q4 dip reflects the collision of lower underwriting margins and higher legacy charges.
Deteriorating. Up 90bps from 91.4% in 24Q4. The primary drivers were a higher loss ratio (+0.8pts) and a slight expense uptick in Specialty. This ends a streak of consistent improvement.
Stable. Up 10% YoY adjusted for dividends. The balance sheet is robust, supported by a prelim statutory surplus of $11.6B (record high).
Guidance
Stable. Implies a 3% increase over 2025 ($2,255M). Q1 2026 is expected to be ~$575M, flat sequentially vs Q4 2025. The explosive growth from rate hikes is leveling off.
Stable. Consistent with the 29.7% achieved in FY25. Management signals that the efficiency gains have largely been realized and they will maintain this level while investing in AI and tech.
Stable. Consistent with the 21.1% effective rate seen in 2025.
Key Questions
Specialty Margin Floor
With the Specialty underlying combined ratio hitting 96% and rates in management liability still flat-to-negative, do you expect further margin deterioration in 2026 before things stabilize?
Growth vs. Retention
Net Written Premium growth slowed to 2% this quarter. Is this the bottom of the deceleration, or should investors expect flat-to-negative growth as you continue to non-renew underpriced business?
Corporate Segment Drag
The A&EP charge was $67M this quarter, significantly higher than the $35M in the prior year. Does this signal increasing pressure on the LPT limit or a change in defense cost trends that will persist?